Adolescence versus adulthood: Differences in basal mesolimbic and nigrostriatal dopamine transmission and response to drugs of abuse

Addict Biol. 2020 Jan;25(1):e12721. doi: 10.1111/adb.12721. Epub 2019 Feb 18.

Abstract

Epidemiological studies have shown that people who begin experimenting drugs of abuse during adolescence are more likely to develop substance use disorders, and the earliest is the beginning of their use, the greatest is the likelihood to become dependent. Understanding the neurobiological changes increasing adolescent vulnerability to drug use is becoming imperative. Although all neurotransmitter systems undergo relevant developmental changes, dopamine system is of particular interest, given its role in a variety of functions related to reward, motivation, and decision making. Thus, in the present study, we investigated differences in mesolimbic and nigrostriatal dopamine transmission between adolescent (5, 6, 7 weeks of age) and adult rats (10-12 weeks of age), in basal conditions and following drug challenge, by using in vivo brain microdialysis. Although no significant difference between adolescents and adults was observed in dopamine basal levels in the nucleus accumbens (NAc)shell and core, reduced DA levels were found in the dorsolateral striatum (DLS) of early and mid-adolescent rats. Adolescent rats showed greater increase of dopamine in the NAc shell following nicotine (0.4 mg/kg), THC (1.0 mg/kg), and morphine (1.0 mg/kg), in the NAc core following nicotine and morphine, and in the DLS following THC, morphine, and cocaine (10 mg/kg). These results, while adding new insight in the development and functionality of the dopamine system during different stages of adolescence, might provide a neurochemical basis for the greater vulnerability of adolescents to drugs of abuse and for the postulated gateway effect of nicotine and THC toward abuse of other illicit substances.

Keywords: adolescence; dopamine; dorso-lateral striatum; drugs of abuse; nucleus accumbens core; nucleus accumbens shell.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Age Factors
  • Analgesics, Opioid / metabolism
  • Analgesics, Opioid / pharmacology
  • Animals
  • Brain / drug effects*
  • Brain / physiopathology
  • Cocaine / metabolism
  • Cocaine / pharmacology*
  • Disease Models, Animal
  • Dopamine / metabolism*
  • Dopamine Uptake Inhibitors / metabolism
  • Dopamine Uptake Inhibitors / pharmacology
  • Dronabinol / metabolism
  • Dronabinol / pharmacology*
  • Ganglionic Stimulants / metabolism
  • Ganglionic Stimulants / pharmacology
  • Male
  • Microdialysis
  • Morphine / metabolism
  • Morphine / pharmacology*
  • Nicotine / metabolism
  • Nicotine / pharmacology*
  • Nucleus Accumbens / drug effects
  • Psychotropic Drugs / metabolism
  • Psychotropic Drugs / pharmacology
  • Rats
  • Substance-Related Disorders / metabolism
  • Substance-Related Disorders / physiopathology
  • Synaptic Transmission / drug effects

Substances

  • Analgesics, Opioid
  • Dopamine Uptake Inhibitors
  • Ganglionic Stimulants
  • Psychotropic Drugs
  • Nicotine
  • Morphine
  • Dronabinol
  • Cocaine
  • Dopamine